COMP <GO>
CMPS vs KLRA // EV/EBITDA & P/E VALUATION
COMPASS Pathways Plc American Depository Shares (NASDAQ) VS. Kailera Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CMPS 0
— KLRA 2
■ METRIC PARITY
LAST: $12.19 (-0.73%) • MKT CAP: $1.69B
valuation
—
LAST: $13.41 (-0.07%) • MKT CAP: $1.74B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CMPS VS. KLRA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CMPS | KLRA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -9.31% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.5 | 52.4 | -6.85 | KLRA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.69B | $1.74B | -$50.5M | KLRA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CMPS REV | KLRA REV | CMPS GROSS % | KLRA GROSS % | CMPS FCF | KLRA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$157.2M | — |
| FY 2024 | $0 | — | — | — | -$119.2M | — |
| FY 2023 | $0 | — | — | — | -$97.4M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CMPS // BETA —
KLRA // BETA —